Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions (pages 272–283)
M. Haas, B. Sis, L. C. Racusen, K. Solez, D. Glotz, R. B. Colvin, M. C. R. Castro, D. S. R. David, E. David-Neto, S. M. Bagnasco, L. C. Cendales, L. D. Cornell, A. J. Demetris, C. B. Drachenberg, C. F. Farver, A. B. Farris III, I. W. Gibson, E. Kraus, H. Liapis, A. Loupy, V. Nickeleit, P. Randhawa, E. R. Rodriguez, D. Rush, R. N. Smith, C. D. Tan, W. D. Wallace, M. Mengel and as the Banff meeting report writing committee
Article first published online: 28 JAN 2014 | DOI: 10.1111/ajt.12590
The 2013 Banff Transplant Conference defines revised, consensus criteria for acute/active and chronic, active antibody-mediated rejection in renal allograft biopsies, criteria that include C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Also see comprehensive review by Djamali et al on page 255.